Quick Answer
AMGEN INC reported Total Revenue of $36.75 billion for fiscal year 2025.
AMGEN INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $36.75B +10.0% |
$33.42B +18.6% |
$28.19B +7.1% |
$26.32B +1.3% |
$25.98B +2.2% |
$25.42B +8.8% |
| Revenue (ASC 606) | $36.75B +10.0% |
$33.42B +18.6% |
$28.19B +7.1% |
$26.32B +1.3% |
$25.98B +2.2% |
$25.42B +8.8% |
| Net Income | $7.71B +88.5% |
$4.09B -39.1% |
$6.72B +2.5% |
$6.55B +11.2% |
$5.89B -18.9% |
$7.26B -7.4% |
| Diluted EPS | $14.23 +88.2% |
$7.56 -39.5% |
$12.49 +3.1% |
$12.11 +17.8% |
$10.28 -16.5% |
$12.31 -4.4% |
| Total Assets | $90.59B -1.4% |
$91.84B -5.5% |
$97.15B +49.2% |
$65.12B +6.5% |
$61.16B -2.8% |
$62.95B +5.4% |
| Cash and Equivalents | $9.13B -23.8% |
$11.97B +9.4% |
$10.94B +43.5% |
$7.63B -4.5% |
$7.99B +27.5% |
$6.27B +3.8% |
| Long-Term Debt | $50.01B -11.6% |
$56.55B -10.5% |
$63.17B +69.1% |
$37.35B +12.4% |
$33.22B +1.0% |
$32.90B +22.1% |
| Stockholders Equity | $8.66B +47.3% |
$5.88B -5.7% |
$6.23B +70.2% |
$3.66B -45.4% |
$6.70B -28.8% |
$9.41B -2.7% |
| Operating Income | $9.08B +25.1% |
$7.26B -8.1% |
$7.90B -17.4% |
$9.57B +25.2% |
$7.64B -16.4% |
$9.14B -5.5% |
| Shares Outstanding | 538.80M +0.4% |
536.90M +0.3% |
535.40M +0.3% |
534.00M -4.4% |
558.30M -3.5% |
578.30M -2.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $9.56B | +12.4% | +4.1% |
| Revenue (ASC 606) | September 30, 2025 | $9.56B | +12.4% | +4.1% |
| Net Income | September 30, 2025 | $3.22B | +13.6% | +124.6% |
| Diluted EPS | September 30, 2025 | $5.93 | +13.6% | +123.8% |
| Total Assets | September 30, 2025 | $90.14B | -0.8% | +2.6% |
| Cash and Equivalents | September 30, 2025 | $9.45B | +4.8% | +17.7% |
| Long-Term Debt | September 30, 2025 | $52.43B | -7.8% | -2.5% |
| Stockholders Equity | September 30, 2025 | $9.62B | +27.8% | +29.5% |
| Operating Income | September 30, 2025 | $2.53B | +23.4% | -4.9% |
| Shares Outstanding | September 30, 2025 | 538.50M | +0.2% | +0.0% |
- AMGEN INC reported Total Revenue of $36.75 billion for fiscal year 2025.
- AMGEN INC showed an increase of +10.0% in Total Revenue compared to the prior fiscal year.
- AMGEN INC reported Revenue (ASC 606) of $36.75 billion for fiscal year 2025.
- AMGEN INC showed an increase of +10.0% in Revenue (ASC 606) compared to the prior fiscal year.
- AMGEN INC reported Net Income of $7.71 billion for fiscal year 2025.
- AMGEN INC showed an increase of +88.5% in Net Income compared to the prior fiscal year.
- AMGEN INC reported Diluted EPS of $14.23 per share for fiscal year 2025.
- AMGEN INC showed an increase of +88.2% in Diluted EPS compared to the prior fiscal year.
- AMGEN INC reported Total Assets of $90.59 billion for fiscal year 2025.
- AMGEN INC showed a decrease of -1.4% in Total Assets compared to the prior fiscal year.
- AMGEN INC reported Cash and Equivalents of $9.13 billion for fiscal year 2025.
- AMGEN INC showed a decrease of -23.8% in Cash and Equivalents compared to the prior fiscal year.
- AMGEN INC reported Long-Term Debt of $50.01 billion for fiscal year 2025.
- AMGEN INC showed a decrease of -11.6% in Long-Term Debt compared to the prior fiscal year.
- AMGEN INC reported Stockholders Equity of $8.66 billion for fiscal year 2025.
- AMGEN INC showed an increase of +47.3% in Stockholders Equity compared to the prior fiscal year.
- AMGEN INC reported Operating Income of $9.08 billion for fiscal year 2025.
- AMGEN INC showed an increase of +25.1% in Operating Income compared to the prior fiscal year.
- AMGEN INC reported Shares Outstanding of 538.80 million shares for fiscal year 2025.
- AMGEN INC showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: